AU6691496A - Enhanced artificial viral envelopes for cellular delivery of therapeutic substances - Google Patents
Enhanced artificial viral envelopes for cellular delivery of therapeutic substancesInfo
- Publication number
- AU6691496A AU6691496A AU66914/96A AU6691496A AU6691496A AU 6691496 A AU6691496 A AU 6691496A AU 66914/96 A AU66914/96 A AU 66914/96A AU 6691496 A AU6691496 A AU 6691496A AU 6691496 A AU6691496 A AU 6691496A
- Authority
- AU
- Australia
- Prior art keywords
- therapeutic substances
- cellular delivery
- viral envelopes
- artificial viral
- enhanced artificial
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8121—Serpins
- C07K14/8125—Alpha-1-antitrypsin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Dispersion Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US690613 | 1985-01-11 | ||
US173895P | 1995-08-01 | 1995-08-01 | |
US001738 | 1995-08-01 | ||
US258095P | 1995-08-21 | 1995-08-21 | |
US002580 | 1995-08-21 | ||
US69061396A | 1996-07-31 | 1996-07-31 | |
PCT/US1996/012750 WO1997004748A2 (en) | 1995-08-01 | 1996-08-01 | Enhanced artificial viral envelopes for cellular delivery of therapeutic substances |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6691496A true AU6691496A (en) | 1997-02-26 |
Family
ID=27356985
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU66914/96A Abandoned AU6691496A (en) | 1995-08-01 | 1996-08-01 | Enhanced artificial viral envelopes for cellular delivery of therapeutic substances |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU6691496A (en) |
WO (1) | WO1997004748A2 (en) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE210145T1 (en) | 1996-04-12 | 2001-12-15 | Univ Pittsburgh | NEW CATIONIC CHOLESTEROL DERIVATIVES WITH CYCLIC POLAR GROUPS |
US6258792B1 (en) | 1996-04-12 | 2001-07-10 | University Of Pittsburgh | Cationic cholesteryl derivatives containing cyclic polar groups |
FR2751222B1 (en) * | 1996-07-16 | 1998-10-09 | Capsulis | COMPOSITIONS CONTAINING AT LEAST ONE NUCLEIC ACID AND THEIR APPLICATIONS IN THE BIOMEDICAL FIELD, PARTICULARLY IN GENE THERAPY |
CA2294579C (en) * | 1997-06-23 | 2007-10-09 | Sequus Pharmaceuticals, Inc. | Liposome-entrapped polynucleotide composition and method |
DE69837453T2 (en) | 1997-07-07 | 2007-12-20 | Medical Research Council | An in vitro sorting procedure |
FR2766706B1 (en) * | 1997-07-30 | 2001-05-25 | Biovector Therapeutics Sa | STABLE PARTICULATE COMPLEXES OF NEUTRAL OR NEGATIVE GLOBAL LOAD OF MULTILAMELLAR STRUCTURE COMPOSED OF AT LEAST ONE BIOLOGICALLY ACTIVE GLOBALLY ANIONIC SUBSTANCE AND A CATIONIC COMPONENT, THEIR PREPARATION AND USE |
FR2766705B1 (en) * | 1997-07-30 | 2001-05-25 | Biovector Therapeutics | PARTICLE COMPLEX OF NEUTRAL OR NEGATIVE GLOBAL CHARGE FORMED OF A CATIONIC OR NEUTRAL VESICLE AND A BIOLOGICALLY ACTIVE ANIONIC SUBSTANCE, THEIR PREPARATION AND THEIR USE |
US6372720B1 (en) * | 1998-02-05 | 2002-04-16 | Kenneth J. Longmuir | Liposome fusion and delivery vehicle |
US6903196B1 (en) | 1999-06-17 | 2005-06-07 | Utah Ventures Ii, L.P. | Methods for identifying and isolating tissue-specific lumen-exposed molecules |
GB0015624D0 (en) * | 2000-06-26 | 2000-08-16 | Nat Cancer Centre | Materials and methods relating to improved gene delivery |
AU2002231637A1 (en) * | 2000-11-22 | 2002-06-03 | Vectron Therapeutics Ag | Production and use of a targeted diagnostic system |
US6713055B2 (en) | 2000-11-27 | 2004-03-30 | Geron Corporation | Glycosyltransferase vectors for treating cancer |
US7491702B2 (en) | 2001-04-18 | 2009-02-17 | The Open University | Polypeptides related to amyloid precursor protein, pharmaceutical compositions thereof, and methods of treatment using the same |
EP2228388A1 (en) * | 2001-04-18 | 2010-09-15 | The Open University | Protected Arg-Glu-Arg polypeptides and uses thereof |
US7622446B2 (en) | 2001-04-18 | 2009-11-24 | The Open University | Polypeptides, derivatives and uses thereof |
AU2002256398A2 (en) * | 2001-04-30 | 2002-11-11 | Targeted Genetics Corporation | Lipid-comprising drug delivery complexes and methods for their production |
EP1399215A4 (en) * | 2001-06-08 | 2004-12-22 | Utah Ventures Ii L P | Tissue-specific endothelial membrane proteins |
WO2004039406A1 (en) * | 2002-11-01 | 2004-05-13 | Genomidea Inc. | Medicinal preparation having chemotherapeutic encapsulated therein |
US20060078893A1 (en) | 2004-10-12 | 2006-04-13 | Medical Research Council | Compartmentalised combinatorial chemistry by microfluidic control |
GB0307428D0 (en) | 2003-03-31 | 2003-05-07 | Medical Res Council | Compartmentalised combinatorial chemistry |
GB0307403D0 (en) | 2003-03-31 | 2003-05-07 | Medical Res Council | Selection by compartmentalised screening |
US20050221339A1 (en) | 2004-03-31 | 2005-10-06 | Medical Research Council Harvard University | Compartmentalised screening by microfluidic control |
US7968287B2 (en) | 2004-10-08 | 2011-06-28 | Medical Research Council Harvard University | In vitro evolution in microfluidic systems |
CN112480257A (en) | 2005-03-23 | 2021-03-12 | 根马布股份公司 | CD38 antibodies for the treatment of multiple myeloma |
EP2363205A3 (en) | 2006-01-11 | 2014-06-04 | Raindance Technologies, Inc. | Microfluidic Devices And Methods Of Use In The Formation And Control Of Nanoreactors |
ATE540750T1 (en) | 2006-05-11 | 2012-01-15 | Raindance Technologies Inc | MICROFLUIDIC DEVICE AND METHOD |
US9562837B2 (en) | 2006-05-11 | 2017-02-07 | Raindance Technologies, Inc. | Systems for handling microfludic droplets |
EP3536396B1 (en) | 2006-08-07 | 2022-03-30 | The President and Fellows of Harvard College | Fluorocarbon emulsion stabilizing surfactants |
US8772046B2 (en) | 2007-02-06 | 2014-07-08 | Brandeis University | Manipulation of fluids and reactions in microfluidic systems |
WO2008130623A1 (en) | 2007-04-19 | 2008-10-30 | Brandeis University | Manipulation of fluids, fluid components and reactions in microfluidic systems |
WO2009058564A2 (en) | 2007-11-01 | 2009-05-07 | Maxygen, Inc. | Immunosuppressive polypeptides and nucleic acids |
EP2315629B1 (en) | 2008-07-18 | 2021-12-15 | Bio-Rad Laboratories, Inc. | Droplet libraries |
WO2010111231A1 (en) | 2009-03-23 | 2010-09-30 | Raindance Technologies, Inc. | Manipulation of microfluidic droplets |
US10520500B2 (en) | 2009-10-09 | 2019-12-31 | Abdeslam El Harrak | Labelled silica-based nanomaterial with enhanced properties and uses thereof |
US10837883B2 (en) | 2009-12-23 | 2020-11-17 | Bio-Rad Laboratories, Inc. | Microfluidic systems and methods for reducing the exchange of molecules between droplets |
US9399797B2 (en) | 2010-02-12 | 2016-07-26 | Raindance Technologies, Inc. | Digital analyte analysis |
US9366632B2 (en) | 2010-02-12 | 2016-06-14 | Raindance Technologies, Inc. | Digital analyte analysis |
US10351905B2 (en) | 2010-02-12 | 2019-07-16 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
JP5934657B2 (en) | 2010-02-12 | 2016-06-15 | レインダンス テクノロジーズ, インコーポレイテッド | Digital specimen analysis |
EP3447155A1 (en) | 2010-09-30 | 2019-02-27 | Raindance Technologies, Inc. | Sandwich assays in droplets |
EP3412778A1 (en) | 2011-02-11 | 2018-12-12 | Raindance Technologies, Inc. | Methods for forming mixed droplets |
EP2675819B1 (en) | 2011-02-18 | 2020-04-08 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
DE202012013668U1 (en) | 2011-06-02 | 2019-04-18 | Raindance Technologies, Inc. | enzyme quantification |
US8841071B2 (en) | 2011-06-02 | 2014-09-23 | Raindance Technologies, Inc. | Sample multiplexing |
US8658430B2 (en) | 2011-07-20 | 2014-02-25 | Raindance Technologies, Inc. | Manipulating droplet size |
US9340784B2 (en) * | 2012-03-19 | 2016-05-17 | Ionis Pharmaceuticals, Inc. | Methods and compositions for modulating alpha-1-antitrypsin expression |
US11901041B2 (en) | 2013-10-04 | 2024-02-13 | Bio-Rad Laboratories, Inc. | Digital analysis of nucleic acid modification |
US9944977B2 (en) | 2013-12-12 | 2018-04-17 | Raindance Technologies, Inc. | Distinguishing rare variations in a nucleic acid sequence from a sample |
EP3090063B1 (en) | 2013-12-31 | 2019-11-06 | Bio-Rad Laboratories, Inc. | Method for detection of latent retrovirus |
US10647981B1 (en) | 2015-09-08 | 2020-05-12 | Bio-Rad Laboratories, Inc. | Nucleic acid library generation methods and compositions |
WO2019222403A2 (en) * | 2018-05-15 | 2019-11-21 | Flagship Pioneering Innovations V, Inc. | Fusosome compositions and uses thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2958076B2 (en) * | 1990-08-27 | 1999-10-06 | 株式会社ビタミン研究所 | Multilamellar liposome for gene transfer and gene-captured multilamellar liposome preparation and method for producing the same |
PL296382A1 (en) * | 1991-02-02 | 1993-11-02 | Nika Health Products Ltd Li Li | Artificial membrane beads containing functionally active peptides responsible for fusion as a drug administering system |
DE4139001A1 (en) * | 1991-11-27 | 1993-06-03 | Boehringer Mannheim Gmbh | PROCESS FOR INJECTION OF NUCLEAR ACIDS IN CELLS |
WO1994018947A1 (en) * | 1993-02-16 | 1994-09-01 | Sharifa Karali | High purity protamine-dna complex and use of same |
ES2231819T3 (en) * | 1995-06-07 | 2005-05-16 | Inex Pharmaceuticals Corp | PARTICULES OF NUCLEIC LIPIDO-ACID PREPARED THROUGH A NIPLEIC HYDROPHOBIC NIPLEIC ACID COMPLEX INTERMEDIATE AND USE TO TRANSFER GENES. |
-
1996
- 1996-08-01 AU AU66914/96A patent/AU6691496A/en not_active Abandoned
- 1996-08-01 WO PCT/US1996/012750 patent/WO1997004748A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1997004748A2 (en) | 1997-02-13 |
WO1997004748A3 (en) | 1997-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6691496A (en) | Enhanced artificial viral envelopes for cellular delivery of therapeutic substances | |
AU6957596A (en) | Implantable drug delivery apparatus | |
AU3560495A (en) | Medicament inhaler | |
AU5928696A (en) | Intracellular delivery of macromolecules | |
AUPO066096A0 (en) | Oral delivery of peptides | |
AU5945296A (en) | Medicament for nasal administration | |
AU6011496A (en) | Improved pharmaceutical compositions for gene therapy | |
ZA965607B (en) | Drug delivery compositions for improved stability of steroids | |
AU7678196A (en) | Methods and compositions for the delivery of monomeric proteins | |
AU3783395A (en) | Drug-loaded elastic membrane and method for delivery | |
AU9224498A (en) | Matrix for controlled delivery of highly soluble drugs | |
AU5869796A (en) | Micromechanical patch for enhancing the delivery of compound s through the skin | |
PL312064A1 (en) | Soft gelatinous form of pharmaceutical dose | |
AUPN411195A0 (en) | Medicinal composition | |
AU7590096A (en) | Drug composition | |
AU3938797A (en) | Transdermal delivery of peptides | |
AU2337897A (en) | Uniform drug delivery therapy | |
AU6015796A (en) | Fused imidazole derivatives and medicinal composition thereof | |
AU6372496A (en) | Absorbent material, absorbent body made of the material, and method for the preparation of the material | |
AU5103196A (en) | Form of administration for applying pharmaceutical substances and auxiliary substances, and process for the preparation thereof | |
AU2559995A (en) | Transdermal delivery of anti-epileptic drugs | |
AU7092196A (en) | Administration of biologically active material | |
AU4843996A (en) | Imidazole derivatives and medicinal composition thereof | |
AU2818097A (en) | Propellant mixture for implantable drug pump | |
AU7000496A (en) | Anti-inflammatory antisense drug |